Abstract
Strontium ranelate (PROTELOS), a divalent strontium salt, has been developed and launched by Servier for the treatment of osteoporosis. Fujisawa Pharmaceutical is developing the drug in Japan; in November 2004, phase II Japanese trials were ongoing.
MeSH terms
-
Animals
-
Bone Resorption / drug therapy
-
Drug Industry / economics
-
Drug Industry / methods
-
Female
-
Humans
-
Organometallic Compounds / chemistry
-
Organometallic Compounds / pharmacology
-
Organometallic Compounds / therapeutic use*
-
Osteoporosis, Postmenopausal / drug therapy
-
Osteoporosis, Postmenopausal / epidemiology
-
Thiophenes / chemistry
-
Thiophenes / pharmacology
-
Thiophenes / therapeutic use*
Substances
-
Organometallic Compounds
-
Thiophenes
-
strontium ranelate